USP7 and breast cancer: The heterogeneous mRNA expression level of USP7 in the molecular breast cancer subtypes (Figure 1E) confirmed our choice to use cell lines with an expression level of USP7 close to the normal tissue of different molecular subtypes and to deregulate the USP7 expression artificially.